Literature DB >> 17494592

Development of a reverse genetics system enabling the rescue of recombinant avian influenza virus A/Turkey/England/50-92/91 (H5N1).

Wendy Howard1, Anna Hayman, Angie Lackenby, Alison Whiteley, Brandon Londt, Jill Banks, John McCauley, Wendy Barclay.   

Abstract

We previously described the use of an established reverse genetics system for the generation of recombinant human influenza A viruses from cloned cDNAs. Here, we have assembled a set of plasmids to allow recovery of the avian H5N1 influenza virus A/Turkey/England/50-92/91 entirely from cDNA. This system enables us to introduce mutations or truncations into the cDNAs to create mutant viruses altered specifically in a chosen gene. These mutant viruses can then be used in future pathogenesis studies in chickens and in studies to understand the host range restrictions of avian influenza viruses in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494592     DOI: 10.1637/7645-050906R1.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  13 in total

1.  Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase.

Authors:  Olivier Moncorgé; Manuela Mura; Wendy S Barclay
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  Investigation of influenza virus polymerase activity in pig cells.

Authors:  Olivier Moncorgé; Jason S Long; Anna V Cauldwell; Hongbo Zhou; Samantha J Lycett; Wendy S Barclay
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

3.  Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays.

Authors:  Camilla T O Benfield; Jon W Lyall; Georg Kochs; Laurence S Tiley
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

4.  Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.

Authors:  Jan Dittmann; Silke Stertz; Daniel Grimm; John Steel; Adolfo García-Sastre; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

5.  Unstable polymerase-nucleoprotein interaction is not responsible for avian influenza virus polymerase restriction in human cells.

Authors:  Anna V Cauldwell; Olivier Moncorgé; Wendy S Barclay
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

6.  The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage.

Authors:  Jason S Long; Wendy A Howard; Alejandro Núñez; Olivier Moncorgé; Samantha Lycett; Jill Banks; Wendy S Barclay
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

7.  The cytoplasmic location of chicken mx is not the determining factor for its lack of antiviral activity.

Authors:  Camilla T O Benfield; Jon W Lyall; Laurence S Tiley
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

8.  Influence of PB2 host-range determinants on the intranuclear mobility of the influenza A virus polymerase.

Authors:  Ágnes Foeglein; Eva M Loucaides; Manuela Mura; Helen M Wise; Wendy S Barclay; Paul Digard
Journal:  J Gen Virol       Date:  2011-04-06       Impact factor: 3.891

9.  Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.

Authors:  Jason Long; Edward Wright; Eleonora Molesti; Nigel Temperton; Wendy Barclay
Journal:  F1000Res       Date:  2015-01-29

10.  Species difference in ANP32A underlies influenza A virus polymerase host restriction.

Authors:  Jason S Long; Efstathios S Giotis; Olivier Moncorgé; Rebecca Frise; Bhakti Mistry; Joe James; Mireille Morisson; Munir Iqbal; Alain Vignal; Michael A Skinner; Wendy S Barclay
Journal:  Nature       Date:  2016-01-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.